MF研究者総覧

教員活動データベース

Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia

発表形態:
資料・解説・論説・研究報告・総合雑誌の論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2022年03月
DOI:
10.7759/cureus.23688
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
*Kyosuke Yamaguchi, Yasushi Kubota, Hiroo Katsuya, Toshihiko Ando, Shinya Kimura
題名:
Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia
発表情報:
Cureus 巻: 14 号: 3 ページ: e23688
キーワード:
allogeneic hematopoietic stem cell transplantation; cord blood; graft-versus-host disease; multicentric castleman disease; tafro syndrome
概要:
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly (TAFRO) syndrome was first reported in 2010 and can occur in association with various potential causes including idiopathic multicentric Castleman disease, infectious diseases, malignancies, and rheumatologic disorders. The diagnostic criteria do not mention a possible association with hematopoietic stem cell transplantation. Here, we present a 56-year-old man who had TAFRO syndrome-like complications after cord blood transplantation (CBT) for acute myeloid leukemia. At two years and seven months after CBT, he was admitted to our hospital with fever, thrombocytopenia, renal insufficiency, and elevated levels of bilirubin and C-reactive protein. Computed tomography images showed bilateral pleural effusion, pelvic ascites, and abdominal lymphadenopathy. Although his symptoms met the diagnostic criteria for TAFRO syndrome, graft-versus-host disease (GVHD) was first suspected, and he was treated with steroid pulse therapy, which was ineffective. The second line of treatment was tocilizumab as a treatment for TAFRO syndrome, which was effective to a certain extent; however, he died two years and 10 months after CBT. This is the first case report of post-transplant complications with TAFRO features, which provides a background for further research into the relationship between post-transplant TAFRO symptoms and GVHD.
抄録:

英語フィールド

Author:
*Kyosuke Yamaguchi, Yasushi Kubota, Hiroo Katsuya, Toshihiko Ando, Shinya Kimura
Title:
Post-transplant Complication With TAFRO Features in a Patient With Acute Myeloid Leukemia
Announcement information:
Cureus Vol: 14 Issue: 3 Page: e23688
Keyword:
allogeneic hematopoietic stem cell transplantation; cord blood; graft-versus-host disease; multicentric castleman disease; tafro syndrome
An abstract:
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly (TAFRO) syndrome was first reported in 2010 and can occur in association with various potential causes including idiopathic multicentric Castleman disease, infectious diseases, malignancies, and rheumatologic disorders. The diagnostic criteria do not mention a possible association with hematopoietic stem cell transplantation. Here, we present a 56-year-old man who had TAFRO syndrome-like complications after cord blood transplantation (CBT) for acute myeloid leukemia. At two years and seven months after CBT, he was admitted to our hospital with fever, thrombocytopenia, renal insufficiency, and elevated levels of bilirubin and C-reactive protein. Computed tomography images showed bilateral pleural effusion, pelvic ascites, and abdominal lymphadenopathy. Although his symptoms met the diagnostic criteria for TAFRO syndrome, graft-versus-host disease (GVHD) was first suspected, and he was treated with steroid pulse therapy, which was ineffective. The second line of treatment was tocilizumab as a treatment for TAFRO syndrome, which was effective to a certain extent; however, he died two years and 10 months after CBT. This is the first case report of post-transplant complications with TAFRO features, which provides a background for further research into the relationship between post-transplant TAFRO symptoms and GVHD.


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.